Obstetrics & Gynecology

Skip Navigation LinksHome > November 2008 - Volume 112 - Issue 5 > Sexual Problems and Distress in United States Women: Prevale...
Obstetrics & Gynecology:
doi: 10.1097/AOG.0b013e3181898cdb
Original Research

Sexual Problems and Distress in United States Women: Prevalence and Correlates

Shifren, Jan L. MD1; Monz, Brigitta U. MD2; Russo, Patricia A. PhD3; Segreti, Anthony PhD4; Johannes, Catherine B. PhD5

Free Access
Article Outline
Collapse Box

Author Information

From the 1Massachusetts General Hospital, Boston, Massachusetts; 2Boehringer Ingelheim GmbH, Ingelheim, Germany; 3PRC Health Services Research and Management Consulting, Washington, DC; 4RTI Health Solutions, Research Triangle Park, North Carolina; and 5RTI Health Solutions, Waltham, Massachusetts.

See related editorial on page 968.

Dr. Segreti is currently affiliated with ASG, Inc., Cary, North Carolina.

Funded by Boehringer Ingelheim International GmbH.

The authors thank TNS Healthcare Inc., especially Kerri Lehrhaupt, for data collection; Lee Bennett From RTI Health Solutions for performing the statistical analysis; and Dr. Ray Rosen of New England Research Institutes for providing expert clinical advice.

Corresponding author: Dr. Jan L. Shifren, Vincent OB/GYN Service, Massachusetts General Hospital, 55 Fruit Street, Yawkey 10-A, Boston, MA 02114; e-mail: jshifren@partners.org.

Financial Disclosure Dr. Shifren has received research support from Proctor & Gamble (Cincinnati, OH) and consulting fees from Proctor & Gamble, Boehringer Ingelheim (Ingelheim, Germany), and Eli Lilly & Co. (Indianapolis, IN). She serves on the scientific advisory board for the New England Research Institutes (Watertown, MA). Dr. Monz is an employee of Boehringer Ingelheim. Dr. Russo is currently under contract with Boehringer Ingelheim and contributed to the development of the manuscript during the contract period. Drs. Segreti and Johannes performed work related to this article under a research contract with Boehringer Ingelheim and their employer, RTI Health Solutions (Research Triangle Park, NC).

Collapse Box


OBJECTIVE: To estimate the prevalence of self-reported sexual problems (any, desire, arousal, and orgasm), the prevalence of problems accompanied by personal distress, and to describe related correlates.

METHODS: The 31,581 female respondents aged 18 years and older were from 50,002 households sampled from a national research panel representative of U.S. women. Correlates of each distressing sexual problem were evaluated using multiple logistic regression techniques.

RESULTS: The age-adjusted point prevalence of any sexual problem was 43.1% and 22.2% for sexually related personal distress (defined as a score of at least 15 on Female Sexual Distress Scale). Any distressing sexual problem (defined as reporting both a sexual problem and sexually related personal distress, Female Sexual Distress Scale score of at least 15) occurred in 12.0% of respondents and was more common in women aged 45–64 years (14.8%) than in younger (10.8%) or older (8.9%) women. Correlates of distressing sexual problems included poor self-assessed health, low education level, depression, anxiety, thyroid conditions, and urinary incontinence.

CONCLUSION: The prevalence of distressing sexual problems peaked in middle-aged women and was considerably lower than the prevalence of sexual problems. This underlines the importance of assessing the prevalence of sexually related personal distress in accurately estimating the prevalence of sexual problems that may require clinical intervention.


Female sexual dysfunction is a term used to describe various sexual problems, such as low desire or interest, diminished arousal, orgasmic difficulties, and dyspareunia. Female sexual dysfunction is considered common, with a widely quoted prevalence estimate of 43% from the U.S. National Health and Social Life Survey1 and similar estimates from other large, population-based surveys in the United States2,3 and the United Kingdom4,5. Most epidemiologic definitions of female sexual dysfunction refer to sexual problems without requiring sexually related personal distress to be present, whereas current diagnostic guidelines from the American Psychiatric Association6 and Food and Drug Administration7 require personal distress as part of the diagnostic criteria for “dysfunction.” The American Urological Association Foundation emphasizes the clinical importance of distress in its revised definitions of sexual disorders.8

Relatively few published epidemiologic studies of female sexual dysfunction have measured personal distress.2,3,9–14 These studies found that only a small proportion of women reporting sexual problems consider them personally distressing.2,3,9–11 To date, only the Women’s International Study of Health and Sexuality (WISHeS) has published prevalence statistics for the United States for sexual problems combined with distress, but this study was limited to sexual desire problems.11–13

The current study, Prevalence of Female Sexual Problems Associated with Distress and Determinants of Treatment Seeking (PRESIDE), is a cross-sectional, population-based survey of female adults in the United States. The purpose was to estimate the prevalence of self-reported sexual problems of desire, arousal, and orgasm, the prevalence of sexually related personal distress, and their combination, and to identify associated factors.

Back to Top | Article Outline


The source population was the TNS [Taylor Nelson Sofres] 6th dimension Global Access Panel. This research panel, balanced on U.S. Census demographic factors, has been used in studies of various medical problems, including urinary incontinence in women.15 The study sample of 50,002 households was designed to represent the U.S. population according to key demographic characteristics (age, race, marital status, education, and income), and the size was determined by an estimated response rate of 50% for a desired yield of 25,000 respondents. Institutional review board approval by the New England Research Institutes was obtained under 45 CFR 46 110(b), category 7 (waiver of written informed consent documentation). Mailed questionnaires were completed during August and September 2006 by eligible participants, a female head of household aged 18 years or older. One reminder postcard was sent within 2 weeks after the questionnaire had been mailed. Demographic information was compiled for nonresponders and compared with responders as key demographic information was available for the entire panel.

Sexual problems were assessed in all respondents without limiting to women reporting recent sexual activity or having a current partner, using the female version of the Changes in Sexual Functioning Questionnaire short-form (CSFQ-14), an instrument with reported reliability and construct validity.16 The CSFQ-14 contains 14 items that use 5-point scales to capture a respondent’s self-evaluation of her current sexual behaviors and problems, from 1=never to 5=every day. For the current analysis only the two clinically relevant response categories of “never=1” or “rarely=2” were used to define sexual problems, similar to the methodology used in WISHeS.12 Questions used to define problems of desire, arousal, and orgasm are listed in the footnotes to Table 2. The single question to identify problems of desire, “How often do you desire to engage in sexual activity,” has direct face validity in a clinical setting. Any sexual problem was defined as the presence of any of the three individual problems of desire, arousal, or orgasm. Sexual pain problems were not assessed, because a physical examination is required for evaluation of dyspareunia.17

Table 2
Table 2
Image Tools

Sexually related personal distress was measured with the Female Sexual Distress Scale (FSDS), an instrument with high reliability, discriminative ability, and construct validity.18 The FSDS measures a woman’s feelings concerning distress about her sex life, assessing guilt, frustration, stress, worry, anger, embarrassment, and unhappiness using a 30-day recall period and a 5-point scale (0=never to 4=always) for each of the 12 items. Responses are summed for an overall score (range 0–48). A score of 15 or higher indicates sexual distress.18 A sexual problem of desire, arousal, or orgasm was considered distressing if associated with personal distress (FSDS score of 15 or more) in accordance with American Psychiatric Association guidelines.6

Covariates included demographic (age, marital and partner status, education, employment, race, ethnicity, and 2005 household income) and health-related and reproductive history information (parity, current use of hormonal contraceptives or hormone therapy, menopausal status, self-assessed health, history of chronic medical conditions, current depression, use of selected medications, and smoking status). Variables were selected based on previously published or expected associations. Quality of life was measured with the Short Form 12 Health Survey (SF-12 version 1).19

Statistical analyses were performed using SAS 9.1 (SAS Institute Inc., Cary, NC).20 The prevalence of each category of sexual problem (and combination of problems) and sexually related personal distress were estimated with corresponding 95% asymptotic normal confidence intervals (CIs).21 In addition, prevalence estimates adjusted for nonresponse associated with demographic factors were calculated using poststratification methods.22 Prevalence estimates were also adjusted for differences between the study population and the U.S. female population, using age, race, and ethnicity (2005 U.S. Census).

To investigate patterns of sexual problems, distress, and distressing sexual problems by age, we calculated the prevalence for reproductive-age women (18–44 years), midaged women (45–64 years), and elderly women (65 years or older).

Age-adjusted prevalence estimates of chronic medical conditions from the current study were descriptively compared with available age-adjusted estimates in U.S. adult females using the 2005 National Health Interview Survey,23 and age trends of mean SF-12 scores were compared with published estimates from the U.S. female population.24

The frequency distribution of covariates for each distressing sexual problem was examined. Multivariable logistic regression was used descriptively to examine all covariates without using model reduction techniques. Results are displayed as adjusted odds ratios with corresponding 95% CI. Based on an observed curvilinear distribution of age, the square of age was used in the multivariable models. Because the education and income variables were strongly correlated, only education was included in the models.

Back to Top | Article Outline


The response rate was 63% (n=31,581). The mean age of respondents was 49 years (range 18–102 years), most (81%) were white, 58% had an education level beyond high school, and 54% were employed either full or part time (Table 1). Most (70%) respondents had a current partner, and 62% were premenopausal. About a quarter (27%) of the sample reported current symptoms of depression, and 13% reported use of antidepressants; 72% reported at least one chronic medical condition other than depression, most commonly hypertension, arthritis, anxiety, thyroid problems, asthma, heart disease, and diabetes. Nonrespondents were younger and more frequently single than respondents and more likely to be employed and have a higher household income. Racial and education distributions were similar between respondents and nonrespondents.

Table 1
Table 1
Image Tools

The most common sexual problem was low desire, with an unadjusted prevalence of 38.7%; less common were low arousal (26.1%) and orgasm difficulties (20.5%) (Table 2). The prevalence of any sexual problem was 44.2%. Sexually related personal distress (FSDS 15 or more) was observed in 22.8% of respondents. Adjustment for age nonresponse resulted in slightly higher prevalence estimates for all sexual problems and a slightly lower estimate for sexually related personal distress. Adjustment for race and ethnicity nonresponse had little effect (data not shown). Age stratification revealed a sharp increase in the prevalence of all three sexual problems by age group (Table 2). Only 27.2% of women aged 18–44 years reported any of the three problems, compared with 44.6% of midaged women and 80.1% of elderly women. Low desire was the most common of the three problems among all age groups. Sexually related personal distress was lowest in elderly women (12.6%), and present in 25.5% and 24.4% of midaged and younger women, respectively (Table 2).

The prevalence of any of the three sexual problems associated with sexually related personal distress (FSDS 15 or more) was 12.0%. The age-stratified prevalence of any distressing sexual problem (Table 3) was highest in women aged 45–64 years (14.8%), lowest in women 65 years or older (8.9%), and intermediate in women aged 18–44 years (10.8%). A similar age pattern was seen for distressing desire and arousal problems, but not for orgasm problems, in which the prevalence was similar in midaged and in older women. The prevalence by 10-year age groups (Fig. 1) provides more detailed information of this underlying age pattern. The joint prevalence of distressing low desire with another distressing sexual problem was less than 5%, and the combination of all three occurred in only 2.3% of women. Adjusting for nonresponse regarding age, race, ethnicity, marital status, education, employment, or income changed the unadjusted point prevalence estimates for the distressing sexual problems by 0.2% or less (data not shown). The same was observed when adjusting for race or ethnicity according to the 2005 U.S. female population. The unadjusted and U.S. population age-adjusted estimates for distressing sexual problems were desire 10.0% and 9.5%; arousal 5.4% and 5.1%; orgasm 4.7% and 4.6%; and any 12.0% and 11.5%, respectively.

Table 3
Table 3
Image Tools
Fig. 1
Fig. 1
Image Tools

Multivariable results for each sexual problem associated with distress (odds ratio and 95% confidence interval) are described as follows (Table 4).

Table 4
Table 4
Image Tools

For distressing desire problems, socioeconomic and demographic variables that were independently and significantly associated included age, race, marital status, partner status, employment, and level of education. The odds of distressing desire problems were higher in middle-aged (35–64 years) women than in younger or older women, and were twice as high in married as in single women, but higher in women without a current partner. The odds increased with each category of worsening self-assessed health compared with excellent health and were approximately 20% higher in postmenopausal than in premenopausal women. Medical conditions positively associated with distressing problems of desire were current depression (odds ratio 2.34), thyroid problems, anxiety, and urinary incontinence.

The observed associations of sociodemographic factors with distressing arousal problems were similar to those observed for desire, except for race. Similar to desire problems, a strong positive association was seen with worsening self-assessed health and current depression. Compared with premenopausal women, the odds of arousal problems with distress were 34% higher in naturally postmenopausal and 54% higher in surgically postmenopausal women. Medical conditions related to increased odds of arousal problems were thyroid problems, arthritis, anxiety, urinary incontinence, and inflammatory or irritable bowel disease.

Sociodemographic variables related to orgasm problems with associated distress were age and education (about 40% more likely in women with lower education). Unlike desire or arousal problems, neither married women nor women without a current partner were more likely to report distressing orgasm problems; instead, a positive association was seen with single (never married) women compared with divorced, widowed, or separated women. Compared with premenopause, only surgical postmenopause was associated with orgasm problems (odds ratio 1.34). Consistent with the other problems, worsening health status and current depression were strongly associated with increased odds of orgasm problems. Medical conditions related to a higher odds of orgasm problems with associated distress included thyroid problems, arthritis, anxiety, and urinary incontinence.

Correlates of any sexual problem associated with distress were very similar to those observed for desire problems. Parity, taking contraceptives or hormone therapy, and taking medication to lower high blood pressure or high cholesterol were not significantly associated with any of the distressing sexual problems.

Back to Top | Article Outline


Self-reported sexual problems, especially low sexual desire, are common, identified in about 40% of U.S. women in this study. Sexual problems associated with personal distress were much less common, although reported by approximately 12% of women. Overall, sexual problems increased with age; however, distressing sexual problems were more common in midaged women than in younger or older women. Despite differences in study designs and nomenclature, the estimated prevalence of any sexual problem found in this study is quite similar to estimates of sexual problems without the distress criterion from other U.S. representative samples1–3 and to sexual problems considered bothersome by older U.S. women.25

The age-adjusted prevalence of sexually related personal distress (22.2%) was comparable to the prevalence of marked sexual distress of 22.8% from a U.S. national sample,2 but published U.S. population-based estimates of distressing sexual problems are not available for comparison. One other study (WISHeS) used similar methodology to define desire problems with associated distress.11 Our prevalence results by 10-year age bands for women ages 20–69 years (6%, 10%, 11%, 13%, and 10%) are comparable to that of European women (7%, 6%, 10%, 13%, and 12%) in WISHeS, but lower than that in U.S. women (15%, 19%, 15%, 13%, and 12%) in WISHeS.11 However WISHeS was restricted to women with a current sexual partner and the sample size was much smaller than ours.

As for representativeness, the age trends of mean SF-12 scores in our respondents were quite similar to that of U.S. females,24 as was the prevalence of antidepressant use,26 cigarette smoking, stroke, asthma, arthritis, and kidney disease.23 Our respondents had a somewhat higher prevalence of hypertension and diabetes and a slightly lower prevalence of coronary heart disease, any heart condition, ulcer, and cancer than U.S. women.23

The prevalence of distressing sexual problems in our sample, particularly desire, peaked in the middle years and declined at the oldest ages. Population-based studies in men have shown a consistent trend toward more frequent sexual dysfunction with increasing age,1,27,28 but the same is not true for women, for whom positive,5,9,12,29 negative,1,30 and no apparent age associations3,30 are reported. Some studies observed that low desire is more common in younger than older women,1,27 whereas others showed an increasing prevalence with age.13,29 Two studies reported low desire more frequently in older than younger women, but sexually related distress was more common in younger women.2,11 The association of age with problems of orgasm and arousal is inconsistent,1,27 but an age-related increase in lubrication problems is well documented.1,2,9,25,27–31

Consistent with the literature, women in this study reporting current depression had more than twice the odds of each type of distressing sexual problem than nondepressed women.32 Some medical conditions, such as diabetes, hypertension, and heart disease are well-known correlates of male sexual problems,33,34 but results from population-based studies in women do not confirm such strong and consistent associations.24,31,35 Neither heart disease nor diabetes was correlated with any of the sexual problems examined in this study.

The finding that sexual problems were greatest in elderly women, but distressing sexual problems least prevalent in this age group is of particular interest and similar to results from WISHeS for distressing desire problems.11 Possible reasons for low levels of distress despite a high prevalence of sexual problems in older women might include the significance of other medical problems, changes in partner status and sexual function, partner physical health problems,25 or the increased importance of other factors in relationships of long duration. Data provided by this survey are unable to address the reason for this finding.

Strengths of the current study include a considerably larger sample size than any other comparable published population-based study, a wide age range, and the use of instruments with published psychometric properties to measure sexual problems and related distress in all respondents, whether or not they were sexually active or with a current partner. Several limitations of the study are worth noting. To increase response rates to sensitive questions, we used a research panel that was not randomly selected. Therefore, respondents in the sample may be more health conscious, self-focused, and have more time to answer mailed questionnaires than females in a random sample. In addition, despite using a research panel, the response rate was only 63%, although comparable to the average response rate (64%) in 54 community-based surveys of female sexual problems.36 The lack of effect that adjusting for demographic factors for nonresponse had and the limited influence of age adjustment for the U.S. female population on the observed prevalence estimates of distressing sexual problems increases confidence that bias according to demographic factors was minimal. Another limitation is that classified sexual problems and distress were based on self-reported information rather than a clinical evaluation, because personally interviewing a large population of women nationwide would be impractical. Last, because the current study was cross-sectional, we cannot attribute causality to any of the correlates identified. Longitudinal data would be useful to determine what intrinsic and extrinsic factors may be related to changes in sexual distress over time.

In conclusion, the results of this study show that sexual problems associated with personal distress occur in about 12% of adult U.S. women, which is much less common than previously published and widely quoted prevalence estimates of about 40% for sexual problems (with unknown presence of distress). Still, the proportion of women with distressing sexual problems is not trivial, particularly for women at mid life, because one in eight women aged 45–64 years had distress associated with desire problems and about one in 15 with arousal and orgasm problems. An accurate estimate of prevalence and identification of correlates of distressing female sexual problems has important implications for the care of women. Clinicians assessing women with sexual problems should be certain to evaluate the level of distress associated with such problems.

Back to Top | Article Outline


1. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors [published erratum appears in JAMA 1999;281:1174]. JAMA 1999;281:537–44.

2. Bancroft J, Loftus J, Long JS. Distress about sex: a national survey of women in heterosexual relationships. Arch Sex Behav 2003;32:193–208.

3. Addis IB, Van Den Eeden SK, Wassel-Fyr CL, Vittinghoff E, Brown JS, Thom DH. Sexual activity and function in middle-aged and older women. Obstet Gynecol 2006;107:755–64.

4. Dunn KM, Croft PR, Hackett GI. Sexual problems: a study of the prevalence and need for health care in the general population. Fam Pract 1998;15:519–24.

5. Nazareth I, Boynton P, King M. Problems with sexual function in people attending London general practitioners: cross sectional study. BMJ 2003;327:423.

6. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington (DC): American Psychiatric Association; 1994.

7. US Department of Health and Human Services. Food and Drug Administration Center for Drug Evaluation and Research. Guidance for Industry. Female Sexual Dysfunction 2000. Available at: http://www.fda.gov/cder/guidance/3312dft.htm. Retrieved November 2, 2007.

8. Basson R, Althof S, Davis S, Fugl-Meyer K, Goldstein I, Leiblum S, et al. Summary of the recommendations on sexual dysfunctions in women. J Sex Med 2004;1:24–34.

9. Osborn M, Hawton K, Gath D. Sexual dysfunction among middle aged women in the community. Br Med J 1988;296:959–62.

10. Öberg K, Sjogren Fugl-Meyer K. On Swedish women’s distressing sexual dysfunctions: some concomitant conditions and life satisfaction. J Sex Med 2005;2:169–80.

11. Hayes RD, Dennerstein L, Bennett CM, Koochaki PE, Leiblum SR, Graziottin A. Relationship between hypoactive sexual desire disorder and aging. Fertil Steril 2007;87:107–12.

12. Leiblum SR, Koochaki PE, Rodenberg CA, Barton IP, Rosen RC. Hypoactive sexual desire disorder in postmenopausal women: U.S. results from the Women’s International Study of Health and Sexuality (WISHeS). Menopause 2006;13:46–56.

13. Dennerstein L, Koochaki P, Barton I, Graziottin A. Hypoactive sexual desire disorder in menopausal women: a survey of Western European women. J Sex Med 2006;3:212–22.

14. Fugl-Meyer AR, Fugl-Meyer KS. Sexual disabilities, problems and satisfaction in 18-74 year old Swedes. Scand J Sexology 1999;2:79–105.

15. Nygaard I, Girts T, Fultz NH, Kinchen K, Pohl G, Sternfeld B. Is urinary incontinence a barrier to exercise in women? Obstet Gynecol 2005;106:307–14.

16. Keller A, McGarvey EL, Clayton AH. Reliability and construct validity of the Changes in Sexual Functioning Questionnaire Short-Form (CSFQ-14). J Sex Marital Ther 2006;32:43–52.

17. Basson R, Brotto LA, Laan E, Redmond G, Utian WH. Assessment and management of women’s sexual dysfunctions: problematic desire and arousal. J Sex Med 2005;2:291–300.

18. Derogatis LR, Rosen R, Leiblum S, Burnett A, Heiman J. The Female Sexual Distress Scale (FSDS): initial validation of a standardized scale for assessment of sexually related personal distress in women. J Sex Marital Ther 2002;28:317–30.

19. Ware J Jr, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220–33.

20. SAS Institute Inc. SAS OnlineDoc 9.1.3. Cary (NC): SAS Institute Inc.; 2004.

21. Kish L. Survey sampling. New York (NY): John Wiley & Sons Inc; 1965.

22. Holt D, Smith TM. Post stratification. J Roy Statist Soc Ser A 1979;142:33–46.

23. Pleis JR, Lethbridge-Cejku M. Summary health statistics for U.S. adults: National Health Interview Survey, 2005. Vital Health Stat 2006;10.

24. Hanmer J, Lawrence WF, Anderson JP, Kaplan RM, Fryback DG. Report of nationally representative values for the noninstitutionalized U.S. adult population for 7 health-related quality-of-life scores. Med Decis Making 2006;26:391–400.

25. Lindau ST, Schumm LP, Laumann EO, Levinson W, O’Muircheartaigh CA, Waite LJ. A study of sexuality and health among older adults in the United States. N Engl J Med 2007;357:762–74.

26. Stagnitti MN. Statistical brief #76. Agency for Healthcare Research and Quality trends in antidepressant use by the U.S. civilian noninstitutionalized population, 1997 and 2002. May 2005. Available at: http://www.meps.ahrq.gov/data_files/publications/st76/stat76.pdf. Retrieved March 3, 2008.

27. Laumann EO, Nicolosi A, Glasser DB, Paik A, Gingell C, Moreira E, et al. Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res 2005;17:39–57.

28. Mercer CH, Fenton KA, Johnson AM, Copas AJ, Macdowall W, Erens B, et al. Who reports sexual function problems? Empirical evidence from Britain’s 2000 National Survey of Sexual Attitudes and Lifestyles. Sex Transm Infect 2005;81:394–9.

29. Safarinejad MR. Female sexual dysfunction in a population-based study in Iran: prevalence and associated risk factors. Int J Impot Res 2006;18:382–95.

30. Ventegodt S. Sex and the quality of life in Denmark. Arch Sex Behav 1998;27:295–307.

31. Richters J, Grulich AE, de Visser RO, Smith AM, Rissel CE. Sex in Australia: sexual difficulties in a representative sample of adults. Aust N Z J Public Health 2003;27:164–70.

32. Bonierbale M, Lancon C, Tignol J. The ELIXIR Study: Evaluation of sexual dysfunction in 4557 depressed patients in France. Curr Med Res Opin 2003;19:114–24.

33. Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, McKinlay JB. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts Male Aging Study. J Urol 2000;163:460–3.

34. Burke JP, Jacobson DJ, McGree ME, Nehra A, Roberts RO, Girman CJ, et al. Diabetes and sexual dysfunction: results from the Olmsted County study of urinary symptoms and health status among men. J Urol 2007;177:1438–42.

35. Abdo CH, Oliveira WM Jr, Moreira ED Jr, Fittipaldi JA. Prevalence of sexual dysfunctions and correlated conditions in a sample of Brazilian women-results of the Brazilian study on sexual behavior (BSSB). Int J Impot Res 2004;16:160–6.

36. Hayes RD, Bennett C, Dennerstein L, Gurrin L, Fairley C. Modeling response rates in surveys of female sexual difficulty and dysfunction. J Sex Med 2007;4:286–95.

Cited By:

This article has been cited 90 time(s).

Endocrine Journal
Acromegaly is associated with higher frequency of female sexual dysfunction: experience of a single center
Celik, O; Hatipoglu, E; Akhan, SE; Uludag, S; Kadioglu, P
Endocrine Journal, 60(6): 753-761.

Journal of Sexual Medicine
My Turn . . . Finally
Goldstein, SW
Journal of Sexual Medicine, 6(2): 301-302.
Journal of Sexual Medicine
Correlates of Sexually Related Personal Distress in Women with Low Sexual Desire
Rosen, RC; Shifren, JL; Monz, BU; Odom, DM; Russo, PA; Johannes, CB
Journal of Sexual Medicine, 6(6): 1549-1560.
Journal of Sexual Medicine
Level of Bother and Treatment-Seeking Predictors Among Male and Female in-Patients with Sexual Problems: A Hospital-Based Study
Evangelia, N; Kirana, PS; Chiu, G; Link, C; Rosen, R; Hatzichristou, D
Journal of Sexual Medicine, 7(2): 700-711.
Journal of Clinical Psychiatry
Distressing Sexual Problems in United States Women Revisited: Prevalence After Accounting for Depression
Johannes, CB; Clayton, AH; Odom, DM; Rosen, RC; Russo, PA; Shifren, JL; Monz, BU
Journal of Clinical Psychiatry, 70(): 1698-1706.
Journal of Sexual Medicine
Cardiovascular Aspects of Sexual Medicine
Jackson, G; Montorsi, P; Adams, MA; Anis, T; El-Sakka, A; Miner, M; Vlachopoulos, C; Kim, E
Journal of Sexual Medicine, 7(4): 1608-1626.
International Urogynecology Journal
Introduction to the 2008 IUGA Sexual Dysfunction in Women Roundtable
Davila, GW
International Urogynecology Journal, 20(): S3-S4.
Risk of hypoactive sexual desire disorder and associated factors in a cohort of oophorectomized women
Castelo-Branco, C; Palacios, S; Combalia, J; Ferrer, M; Traveria, G
Climacteric, 12(6): 525-532.
Archives of Gynecology and Obstetrics
Severe menopausal symptoms in middle-aged women are associated to female and male factors
Chedraui, P; Perez-Lopez, FR; Mendoza, M; Morales, B; Martinez, MA; Salinas, AM; Hidalgo, L
Archives of Gynecology and Obstetrics, 281(5): 879-885.
Reproductive Health Matters
Sexual problems among women in the United States
Reproductive Health Matters, 17(): 221-222.

Journal of Sexual Medicine
Prevalence and Potential Risk Factors of Female Sexual Difficulties: An Urban Iranian Population-Based Study
Goshtasebi, A; Vahdaninia, M; Foroshani, AR
Journal of Sexual Medicine, 6(): 2988-2996.
Journal of Sexual Medicine
Socioeconomic, Anthropomorphic, and Demographic Predictors of Adult Sexual Activity in the United States: Data from the National Survey of Family Growth
Eisenberg, ML; Shindel, AW; Smith, JF; Breyer, BN; Lipshultz, LI
Journal of Sexual Medicine, 7(1): 50-58.
Social Science & Medicine
Framing disease: The example of female hypoactive sexual desire disorder
Jutel, A
Social Science & Medicine, 70(7): 1084-1090.
DHEA for postmenopausal women: A review of the evidence
Panjari, M; Davis, SR
Maturitas, 66(2): 172-179.
Journal of Sexual Medicine
Who is the 40-Year-Old Virgin and Where Did He/She Come From? Data from the National Survey of Family Growth
Eisenberg, ML; Shindel, AW; Smith, JF; Lue, TF; Walsh, TJ
Journal of Sexual Medicine, 6(8): 2154-2161.
Journal of Sexual Medicine
Endocrine Aspects of Women's Sexual Function
Wierman, ME; Nappi, RE; Avis, N; Davis, SR; Labrie, F; Rosner, W; Shifren, JL
Journal of Sexual Medicine, 7(1): 561-585.
Archives of Sexual Behavior
The DSM Diagnostic Criteria for Female Sexual Arousal Disorder
Graham, CA
Archives of Sexual Behavior, 39(2): 240-255.
Journal of Sexual Medicine
The HSDD Registry for Women: A Novel Patient Registry for Women with Generalized Acquired Hypoactive Sexual Desire Disorder
Rosen, RC; Connor, MK; Maserejian, NN
Journal of Sexual Medicine, 7(5): 1747-1756.
Journal of Sexual Medicine
Acute and Repeated Flibanserin Administration in Female Rats Modulates Monoamines Differentially Across Brain Areas: A Microdialysis Study
Allers, KA; Dremencov, E; Ceci, A; Flik, G; Ferger, B; Cremers, TIFH; Ittrich, C; Sommer, B
Journal of Sexual Medicine, 7(5): 1757-1767.
Impact of Tadalafil Once Daily in Men With Erectile Dysfunction-Including a Report of the Partners' Evaluation
Althof, SE; Rubio-Aurioles, E; Kingsberg, S; Zeigler, H; Wong, DG; Burns, P
Urology, 75(6): 1358-1363.
Journal of Affective Disorders
Early-onset major depressive disorder in men is associated with childlessness
Yates, WR; Meller, WH; Lund, BC; Thurber, S; Grambsch, PL
Journal of Affective Disorders, 124(): 187-190.
Annals of Pharmacotherapy
Assessing the Clinical Efficacy of Sildenafil for the Treatment of Female Sexual Dysfunction
Brown, DA; Kyle, JA; Ferrill, MJ
Annals of Pharmacotherapy, 43(): 1275-1285.
Journal of Sexual Medicine
Responses to the Proposed DSM-V Changes
Derogatis, LR; Laan, E; Brauer, M; van Lunsen, RHW; Jannini, EA; Davis, SR; Fabre, L; Smith, LC; Basson, R; Guay, AT; Rubio-Aurioles, E; Goldstein, A; Pukall, C; Kellogg, S; Burrows, L; Morrison, P; Krychman, M; Goldstein, SW; Goldstein, I
Journal of Sexual Medicine, 7(6): 1998-2014.
Journal of Sexual Medicine
Menopause Leading to Increased Vaginal Wall Thickness in Women with Genital Prolapse: Impact on Sexual Response
Lara, LAD; da Silva, AR; Rosa-e-Silva, JC; Chaud, F; Silva-de-Sa, MF; Silva, ARME; Rosa-e-Silva, ACJD
Journal of Sexual Medicine, 6(): 3097-3110.
LEI (Lack of tEstosterone Impact) survey in a clinical sample with surgical menopause
Nappi, RE; Lello, S; Melis, GB; Albani, F; Polatti, F; Genazzani, AR
Climacteric, 12(6): 533-540.
International Journal of Clinical Practice
What do men and women ask a helpline on sexual concerns? Results of an Italian telephone counselling service
Simonelli, C; Tripodi, F; Cosmi, V; Rossi, R; Fabrizi, A; Silvaggi, C; Di Pomponio, I
International Journal of Clinical Practice, 64(3): 360-370.
Journal of Sexual Medicine
Sexual Functioning among Women with and without Diabetes in the Boston Area Community Health Study
Wallner, LP; Sarma, AV; Kim, C
Journal of Sexual Medicine, 7(2): 881-887.
Journal of Sexual Medicine
Is One Question Enough to Detect Female Sexual Dysfunctions? A Diagnostic Accuracy Study in 6,194 Women
Kriston, L; Gunzler, C; Rohde, A; Berner, MM
Journal of Sexual Medicine, 7(5): 1831-1841.
Naunyn-Schmiedebergs Archives of Pharmacology
Flibanserin, a drug intended for treatment of hypoactive sexual desire disorder in pre-menopausal women, affects spontaneous motor activity and brain neurochemistry in female rats
Ferger, B; Shimasaki, M; Ceci, A; Ittrich, C; Allers, KA; Sommer, B
Naunyn-Schmiedebergs Archives of Pharmacology, 381(6): 573-579.
Journal of Family Practice
From whence comes HSDD?
Parish, SJ
Journal of Family Practice, 58(7): S16-S21.

Ginekologia Polska
Hypoactive sexual desire disorder
Marcin, P; Marek, S
Ginekologia Polska, 80(7): 518-522.

Journal of Sex Research
Elucidating Women's (hetero)Sexual Desire: Definitional Challenges and Content Expansion
Meana, M
Journal of Sex Research, 47(): 104-122.
Journal of Postgraduate Medicine
Prevalence and risk factors for female sexual dysfunction in women attending a medical clinic in south India
Singh, JC; Tharyan, P; Kekre, NS; Singh, G; Gopalakrishnan, G
Journal of Postgraduate Medicine, 55(2): 113-120.
Journal of Sexual Medicine
Approved Hormonal Treatments for HSDD: An Unmet Medical Need
Snabes, MC; Simes, SM
Journal of Sexual Medicine, 6(7): 1846-1849.
Journal of Sexual Medicine
More than Sexual Function: Predictors of Sexual Satisfaction in a Sample of Women Age 40-70
Dundon, CM; Rellini, AH
Journal of Sexual Medicine, 7(2): 896-904.
Journal of Sexual Medicine
The Impairment of Sexual Function Is Less Distressing for Menopausal than for Premenopausal Women
Berra, M; De Musso, F; Matteucci, C; Martelli, V; Perrone, AM; Pelusi, C; Pelusi, G; Meriggiola, MC
Journal of Sexual Medicine, 7(3): 1209-1215.
Obstetrics and Gynecology Clinics of North America
Female Sexual Dysfunction
Clayton, AH; Hamilton, DV
Obstetrics and Gynecology Clinics of North America, 36(4): 861-+.
Acta Neurologica Scandinavica
Female sexuality in multiple sclerosis: the multidimensional nature of the problem and the intervention
Bronner, G; Elran, E; Golomb, J; Korczyn, AD
Acta Neurologica Scandinavica, 121(5): 289-301.
Archives of Sexual Behavior
The DSM Diagnostic Criteria for Hypoactive Sexual Desire Disorder in Women
Brotto, LA
Archives of Sexual Behavior, 39(2): 221-239.
Journal of Sex Research
Sexual Dysfunction in Women with Diabetes Mellitus
Giraldi, A; Kristensen, E
Journal of Sex Research, 47(): 199-211.
Local estrogens for quality of life and sexuality in postmenopausal women with cardiovascular disease
Nappi, RE; Albani, F; Chiovato, L; Polatti, F
Climacteric, 12(): 112-116.
Archives of Sexual Behavior
The DSM Diagnostic Criteria for Female Orgasmic Disorder
Graham, CA
Archives of Sexual Behavior, 39(2): 256-270.
Geburtshilfe Und Frauenheilkunde
Incidence, Diagnosis, and Management of Female Sexual Dysfunction in Gynecological Practice - a Representative Survey in Germany
Berner, M; Schmidt, E; Weinhaupl, C; Gunzler, C; Kriston, L; Zahradnik, HP
Geburtshilfe Und Frauenheilkunde, 70(4): 281-287.
Journal of Sexual Medicine
The Place of Female Sexual Dysfunction in the Urological Practice: Results of a Dutch Survey
Bekker, M; Beck, J; Putter, H; van Driel, M; Pelger, R; Nijeholt, ALA; Elzevier, H
Journal of Sexual Medicine, 6(): 2979-2987.
Journal of Sexual Medicine
Women's Sexual Desire and Arousal Disorders
Brotto, LA; Bitzer, J; Laan, E; Leiblum, S; Luria, M
Journal of Sexual Medicine, 7(1): 586-614.
Psychiatric Clinics of North America
Female Sexual Dysfunction
Clayton, AH; Hamilton, DV
Psychiatric Clinics of North America, 33(2): 323-+.
Journal of Womens Health
Help-Seeking Behavior of Women with Self-Reported Distressing Sexual Problems
Shifren, JL; Johannes, CB; Monz, BU; Russo, PA; Bennett, L; Rosen, R
Journal of Womens Health, 18(4): 461-468.
Nature Reviews Urology
Sildenafil citrate for female sexual arousal disorder: a future possibility?
Schoen, C; Bachmann, G
Nature Reviews Urology, 6(4): 216-222.
Epidemiology of female sexual dysfunction
Palacios, S; Castano, R; Grazziotin, A
Maturitas, 63(2): 119-123.
The challenge of talking about sex: The importance of patient-physician interaction
Brandenburg, U; Bitzer, J
Maturitas, 63(2): 124-127.
Journal of Thoracic Disease
Sexuality and breast cancer: prime time for young patients
Pinto, AC
Journal of Thoracic Disease, 5(): S81-S86.
Journal of Sexual Medicine
Sexual Dysfunction and DistressDevelopment of a Polish Version of the Female Sexual Distress Scale-Revised
Nowosielski, K; Wrobel, B; Sioma-Markowska, U; Poreba, R
Journal of Sexual Medicine, 10(5): 1304-1312.
European Neuropsychopharmacology
The use of dehydroepiandrosterone in the treatment of hypoactive sexual desire disorder: A report of gender differences
Bloch, M; Meiboom, H; Zaig, I; Schreiber, S; Abramov, L
European Neuropsychopharmacology, 23(8): 910-918.
Journal of Sexual Medicine
The Comparison of the Relationship Between Sociocultural-Economic Features and Sexual Dysfunction Frequency in Sexually Active Premenopausal Female Patients on Renal Replacement Therapy
Koca, TG; Koca, N; Ersoy, A
Journal of Sexual Medicine, 9(): 3171-3179.
Pharmacogenomics and sexuality: a vision
Nappi, RE; Domoney, C
Climacteric, 16(): 25-30.
Journal of Sex & Marital Therapy
Motivations and Sexual Attitudes, Experiences, and Behavior of Sexuality Professionals
Luria, M; Byers, ES; Voyer, SD; Mock, M
Journal of Sex & Marital Therapy, 39(2): 112-131.
Journal of Sex & Marital Therapy
Validity of the Decreased Sexual Desire Screener for Diagnosing Hypoactive Sexual Desire Disorder
Clayton, AH; Goldfischer, E; Goldstein, I; DeRogatis, L; Nappi, R; Lewis-D'Agostino, DJ; Kimura, T; Hebert, A; Pyke, R
Journal of Sex & Marital Therapy, 39(2): 132-143.
International Journal of Impotence Research
Sexual dysfunction assessment and hormonal correlations in patients with polycystic ovary syndrome
Ercan, CM; Coksuer, H; Aydogan, U; Alanbay, I; Keskin, U; Karasahin, KE; Baser, I
International Journal of Impotence Research, 25(4): 127-132.
Bmc Medical Informatics and Decision Making
Analyzing the impact of social factors on homelessness: a Fuzzy Cognitive Map approach
Mago, VK; Morden, HK; Fritz, C; Wu, TK; Namazi, S; Geranmayeh, P; Chattopadhyay, R; Dabbaghian, V
Bmc Medical Informatics and Decision Making, 13(): -.
International Journal of Impotence Research
Associations of desire for change in sexual life amongst female medical students in North America
Shindel, AW; Breyer, BN; Smith, JF
International Journal of Impotence Research, 25(2): 74-79.
Journal of Sexual Medicine
A Phase 2a Multicenter, Double-Blind, Placebo-Controlled, Crossover Trial to Investigate the Efficacy, Safety, and Toleration of CP-866,087 (a High-Affinity Mu-Opioid Receptor Antagonist) in Premenopausal Women Diagnosed with Female Sexual Arousal Disorder (FSAD)
Orri, M; Abraham, L; Giraldi, A
Journal of Sexual Medicine, 10(): 2484-2496.
Diabetes Care
Effect of Intensive Lifestyle Intervention on Sexual Dysfunction in Women With Type 2 Diabetes Results from an ancillary Look AHEAD study
Wing, RR; Bond, DS; Gendrano, IN; Wadden, T; Bahnson, J; Lewis, CE; Brancati, F; Schneider, S; Kitabchi, AE; Van Dorsten, B; Rosen, RC
Diabetes Care, 36(): 2937-2944.
Journal of Sexual Medicine
Efficacy of Flibanserin in Women with Hypoactive Sexual Desire Disorder: Results from the BEGONIA Trial
Katz, M; DeRogatis, LR; Ackerman, R; Hedges, P; Lesko, L; Garcia, M; Sand, M
Journal of Sexual Medicine, 10(7): 1807-1815.
Sexuality of Chinese women around menopause
Lo, SST; Kok, WM
Maturitas, 74(2): 190-195.
European Journal of Obstetrics & Gynecology and Reproductive Biology
Comparison of prevalence of hypoactive sexual desire disorder (HSDD) in women after five different hysterectomy procedures
Lermann, J; Haberle, L; Merk, S; Henglein, K; Beckmann, MW; Mueller, A; Mehlhorn, G
European Journal of Obstetrics & Gynecology and Reproductive Biology, 167(2): 210-214.
Sexual dysfunctions and outpatient psychotherapy
Hoyer, J
Psychotherapeut, 58(4): 371-378.
Sexual and Relationship Therapy
Consequences of impaired female sexual functioning: Individual differences and associations with sexual distress
Stephenson, KR; Meston, CM
Sexual and Relationship Therapy, 27(4): 344-357.
Journal of Sexual Medicine
Distress, Sexual Dysfunctions, and DSM: Dialogue at Cross Purposes?
Hendrickx, L; Gijs, L; Enzlin, P
Journal of Sexual Medicine, 10(3): 630-641.
Journal of Sexual Medicine
Toward Personalized Sexual Medicine (Part 1): Integrating the "Dual Control Model" into Differential Drug Treatments for Hypoactive Sexual Desire Disorder and Female Sexual Arousal Disorder
Bloemers, J; van Rooij, K; Poels, S; Goldstein, I; Everaerd, W; Koppeschaar, H; Chivers, M; Gerritsen, J; van Ham, D; Olivier, B; Tuiten, A
Journal of Sexual Medicine, 10(3): 791-809.
Progres En Urologie
Women's orgasmic disorders
Colson, MH; Cour, F
Progres En Urologie, 23(9): 586-593.
Sexuality and Disability
Prevalence of Sexual Dysfunctions Among Women with Multiple Sclerosis
Lew-Starowicz, M; Rola, R
Sexuality and Disability, 31(2): 141-153.
Fertility and Sterility
Managing female sexual dysfunction
Buster, JE
Fertility and Sterility, 100(4): 905-915.
Journal of Sexual Medicine
Standard Operating Procedures for Taking a Sexual History
Althof, SE; Rosen, RC; Perelman, MA; Rubio-Aurioles, E
Journal of Sexual Medicine, 10(1): 26-35.
Journal of Sexual Medicine
Sexual Desire and Hypoactive Sexual Desire Disorder in Women. Introduction and Overview. Standard Operating Procedure (SOP Part 1)
Bitzer, J; Giraldi, A; Pfaus, J
Journal of Sexual Medicine, 10(1): 36-49.
Journal of Sexual Medicine
Female Sexual Arousal Disorders
Giraldi, A; Rellini, AH; Pfaus, J; Laan, E
Journal of Sexual Medicine, 10(1): 58-73.
Journal of Sexual Medicine
Standard Operating Procedures for Female Orgasmic Disorder: Consensus of the International Society for Sexual Medicine
Laan, E; Rellini, AH; Barnes, T
Journal of Sexual Medicine, 10(1): 74-82.
Journal of Sexual Medicine
Standard Operational Procedures for Low Sexual Desire in Men
Rubio-Aurioles, E; Bivalacqua, TJ
Journal of Sexual Medicine, 10(1): 94-107.
Journal of Sex Research
Bringing Sex Research into the 21st Century: Genetic and Epigenetic Approaches on Female Sexual Function
Burri, A
Journal of Sex Research, 50(): 318-328.
Asia-Pacific Psychiatry
Sexual desire disorder in female healthcare personnel in Malaysia
Grewal, GS; Gill, JS; Sidi, H; Gurpreet, K; Jambunathan, ST; Suffee, NJ
Asia-Pacific Psychiatry, 5(): 14-20.
Journal of Sexual Medicine
The Impact of Parental Bonding on Sexual Distress in Women with Type 1 Diabetes Mellitus
Bargiota, A; Dimitropoulos, K; Mouzas, O; Melekos, M; Tzortzis, V; Koukoulis, G
Journal of Sexual Medicine, 10(2): 378-385.
Journal of Sexual Medicine
Peripheral Polyneuropathy and Female Sexual DysfunctionFamilial Amyloidotic Polyneuropathy as an Example Besides Diabetes Mellitus
Oliveira-e-Silva, T; Pinheiro, LC; Mendes, JR; Barroso, E; Pereira, NM
Journal of Sexual Medicine, 10(2): 430-438.
Breast Cancer Research and Treatment
The impact of endocrine therapy on sexual dysfunction in postmenopausal women with early stage breast cancer: encouraging results from a prospective study
Frechette, D; Paquet, L; Verma, S; Clemons, M; Wheatley-Price, P; Gertler, SZ; Song, XN; Graham, N; Dent, S
Breast Cancer Research and Treatment, 141(1): 111-117.
Journal of Sexual Medicine
Characterization of Orgasmic Difficulties by Women: Focus Group Evaluation
Kingsberg, SA; Tkachenko, N; Lucas, J; Burbrink, A; Kreppner, W; Dickstein, JB
Journal of Sexual Medicine, 10(9): 2242-2250.
Journal of Sexual Medicine
Correlation of Question 15 of the FSDS-DAO with Clinician Evaluation of Female Orgasmic Disorder
Dickstein, JB; Goldstein, SW; Tkachenko, N; Kreppner, W
Journal of Sexual Medicine, 10(9): 2251-2254.
Clinical Obstetrics and Gynecology
Partnership Issues and Sexuality
Clinical Obstetrics and Gynecology, 52(4): 656-665.
PDF (227) | CrossRef
Clinical Obstetrics and Gynecology
Sexual Pain
Clinical Obstetrics and Gynecology, 52(4): 682-690.
PDF (109) | CrossRef
Obstetrics & Gynecology
Sexual Dysfunction Prevalence Rates: Marketing or Real?
Nygaard, I
Obstetrics & Gynecology, 112(5): 968-969.
PDF (133) | CrossRef
Journal of Cardiovascular Nursing
Sexual Dysfunction in Women With Cardiovascular Disease: What Do We Know?
Steinke, EE
Journal of Cardiovascular Nursing, 25(2): 151-158.
PDF (156) | CrossRef
The sexual health benefits of oral low-dose estrogen plus progestogen and vaginal estrogen for postmenopausal women
Kingsberg, SA
Menopause, 16(2): 224-225.
PDF (53) | CrossRef
Sexual function in middle-aged Latin American women as determined by the Female Sexual Function Index: improving global acceptance of the use of validated measures of sexual function
Kingsberg, SA
Menopause, 16(6): 1089-1091.
PDF (57) | CrossRef
Back to Top | Article Outline

© 2008 The American College of Obstetricians and Gynecologists



Looking for ABOG articles? Visit our ABOG MOC II collection. The selected Green Journal articles are free through the end of the calendar year.


If you are an ACOG Fellow and have not logged in or registered to Obstetrics & Gynecology, please follow these step-by-step instructions to access journal content with your member subscription.

Article Tools



Article Level Metrics